Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact
Open Access
- 6 April 2013
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 31 (23), 2638-2646
- https://doi.org/10.1016/j.vaccine.2013.03.034
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health Research (RDA/03/07/014, PDF-2012-05-245, PDA/02/06/088)
This publication has 39 references indexed in Scilit:
- Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of LifeThe Pediatric Infectious Disease Journal, 2010
- Characterization of fHbp , nhba ( gna2132 ), nadA , porA , and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal VaccineClinical and Vaccine Immunology, 2010
- Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd ImmunityClinical and Vaccine Immunology, 2010
- Global epidemiology of meningococcal diseaseVaccine, 2009
- On the relationship between meningococcal transmission dynamics and disease: Remarks on humoral immunityVaccine, 2009
- Social Contacts and Mixing Patterns Relevant to the Spread of Infectious DiseasesPLoS Medicine, 2008
- A universal vaccine for serogroup B meningococcusProceedings of the National Academy of Sciences, 2006
- Reassessing the Cost-Effectiveness of Meningococcal Serogroup C Conjugate (MCC) Vaccines Using a Transmission Dynamic ModelMedical Decision Making, 2006
- DIFFICULT AND RECURRENT MENINGITISJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Invasive meningococcal and pneumococcal disease in Switzerland: cost?utility analysis of different vaccine strategiesVaccine, 2003